CollPlant Biotechnologies (CLGN) Capital Expenditures Growth (3y) (2021 - 2025)
CollPlant Biotechnologies (CLGN) Capital Expenditures Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77.25% |
| Sep 30, 2025 | 85.21% |
| Jun 30, 2025 | 80.12% |
| Dec 31, 2024 | 65.43% |
| Sep 30, 2024 | 38.61% |
| Jun 30, 2024 | 5.84% |
| Mar 31, 2024 | 12.64% |
| Dec 31, 2023 | 19.38% |
| Sep 30, 2023 | -41.37% |
| Jun 30, 2023 | -27.92% |
| Mar 31, 2023 | -19.49% |
| Dec 31, 2022 | -55.78% |
| Sep 30, 2022 | -48.69% |
| Jun 30, 2022 | -3.06% |
| Mar 31, 2022 | 25.33% |
| Dec 31, 2021 | -152.22% |
| Sep 30, 2021 | -84.07% |
| Jun 30, 2021 | 17.94% |
| Mar 31, 2021 | 16.06% |